• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Kopran Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Parijat
  • BSE Code : 2717.0
  • ISIN : INE082A01010
159.07 -2 (-1.27%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    158.25

  • Today’s High

    161.79

  • Open

    160.01

  • Perv Close

    161.11

  • 52W Low

    155.00

  • 52W High

    369.70

Key Indicators

  • P/E(TTM)

    29.38

  • Mar.Cap (₹Cr.)

    768.08

  • Div & Yield %

    1.88

  • Book Value(₹)

    89.35

  • Debt-Equity Ratio

    -1.27

  • AGM Date

    01-Aug-2025

  • EPS

    5.41

  • P/E Ratio

    29.38

Financials Ratios

  • Debt-Equity Ratio

    0.19

  • Mar.Cap (₹Cr.)

    768.08

  • RONW (%)

    10.95

  • ROCE (%)

    13.57

Score Board

  • Equity (₹ in Cr.)

    48.29

  • BV (₹)

    89.40

  • Sales( ₹ in Cr.)

    271.01

  • NP (in Cr.)

    26.86

  • NP Var(%)

    -22.0

  • Div%

    30.0

  • CPS (₹)

    6.60

  • EPS (₹)

    5.60

  • Traded Value (₹ in Lakhs)

    767.50

  • 52 Week High

    369.70

  • 52 Week Low

    155.00

  • Price BSE

    159.0

  • Price NSE

    159.00

  • Market Capital( in Cr.)

    767.50

  • P/C Ratio

    24.10

  • P/E Ratio

    28.60

  • Price Vs.BV

    5.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 337.46 273.09 204.52 222.83 179.29 196.65
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 337.46 273.09 204.52 222.83 179.29 196.65
Other Income 16.71 16.09 8.03 10.41 1.99 3.10
Stock Adjustments 1.74 -3.55 3.93 -14.70 17.33 -0.47
Total Income 355.91 285.63 216.48 218.54 198.61 199.28
EXPENDITURE :            
Raw Materials 231.89 174.14 131.75 123.04 118.50 116.89
Power and Fuel Cost 7.89 7.58 6.51 5.68 6.21 6.30
Employee Cost 25.61 25.15 21.05 18.34 20.02 20.38
Other Manufacturing Expenses 12.45 10.69 9.75 8.33 7.28 8.89
Selling and Administration Expenses 22.45 20.85 22.65 19.79 19.54 19.32
Miscellaneous Expenses 1.98 3.23 1.31 2.75 1.90 1.57
Employee Benefit Expenses 25.61 25.15 21.05 18.34 20.02 20.38
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 302.26 241.63 193.03 177.93 173.45 173.35
Operating Profit 53.64 44.00 23.44 40.62 25.16 25.92
Interest 4.50 2.67 2.95 3.81 5.96 5.46
Gross Profit 49.14 41.33 20.49 36.81 19.20 20.46
Depreciation 4.62 4.41 4.32 4.10 3.47 3.11
Profit Before Tax 44.52 36.92 16.17 32.71 15.73 17.35
Current Tax 10.08 5.87 3.75 5.76 2.80 3.48
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.20 -0.21 0.67 3.48 1.71 0.91
Reported Net Profit 34.64 31.25 11.74 23.47 11.22 12.97
Extraordinary Items 0.00 0.00 0.00 -0.01 -0.04 -0.04
Adjusted Net Profit 34.64 31.25 11.74 23.48 11.26 13.01
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 -0.07
P & L Balance brought forward 79.20 62.41 57.15 40.17 28.95 16.05
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 14.46 14.46 6.49 6.49 0.00 0.00
P & L Balance carried down 99.38 79.20 62.41 57.15 40.17 28.95
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 30.00 30.00 30.00 30.00 0.00 0.00
Dividend Per Share(Rs) 3.00 3.00 3.00 3.00 0.00 0.00
Earnings Per Share-Unit Curr 7.18 6.48 2.44 5.43 2.59 3.00
Earnings Per Share(Adj)-Unit Curr 7.18 6.48 2.44 5.43 2.59 3.00
Book Value 86.47 82.05 78.56 57.07 53.10 50.51
Book Value(Adj)-Unit Curr 86.47 82.05 78.56 57.07 53.10 50.51

Shareholding Pattern

  • Promoter Group

    44.42%

  • Public Share Holding

    55.58%

  • Custodian

    0.00%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 17,795,993 36.86 17,795,993 6
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,653,210 7.57 3,653,210 11
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 21,449,203 44.42 21,449,203 17
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 600 0.00 300 4
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 364,701 0.76 364,701 26
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 300 0.00 0 3
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 1,511 0.00 1,011 5
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 367,112 0.76 366,012 38
2] Non Institution
Bodies Corporate 2,835,946 5.87 2,816,346 325
Clearing Members 61,329 0.13 61,329 23
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,628,212 3.37 1,628,062 911
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,259,076 2.61 1,259,076 1,306
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 3,683,993 7.63 3,683,993 64
Individuals holding nominal share capital up to Rs. 1 lakh 16,996,786 35.20 16,758,263 57,506
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1,948 0.00 1,948 2
Others 1,500 0.00 1,500 1
Sub Total 26,468,790 54.82 26,210,517 60,138
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 500 0.00 500 1
Total Shares held by Custodians and against which Depository Receipts have been issued 500 0.00 500 1
Grand Total ( A + B + C ) 48,285,605 100.00 48,026,232 60,194

Company Background

Kopran LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Kopran Ltd
  • BSE Code : 2717.0
  • ISIN : INE082A01010

  • Incorporation Year

    1958

  • Registered Office

    Parijat House 1076
    Dr E Moses Road Worli, Mumbai,
    Maharashtra-400018

  • Telephone

    91-22-43661111

  • FAX

    91-22-24950363

  • Chairman

    Susheel Somani

  • Managing Director

  • Company Secretary

    Sunil Sodhani

  • Auditor

    Khandelwal Jain & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No 56-2 ,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Kopran Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Kopran 158.95 354.17 337.46 29.38 11.24
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10